May 8, 2000 - MED-MINDER INITIATES FIELD TEST OF MEDICAL COMPLIANCE PRODUCT
ZTEST Electronics Inc., ZTST - CDN, ("ZTEST") wishes to announce that its Strategic Partner Med-Minder Enterprises Inc. ("Med-Minder"), has initiated field trials for its new medical compliance product, which is focused on helping the rapidly growing segment of the population that must cope with the need for taking their prescription drugs on a timely basis.
Med-Minder has developed a proprietary system for the dispensing of medications. The system consists of a portable dispensing device, PC based software able to communicate with existing programs used by pharmacies and a communications protocol between the dispenser and the software. ZTEST has completed the development necessary to take this product from the concept stage to the pre-commercial stage. ZTEST also manufactured the products being used in these field trials.
Med-Minder has now installed its software in ten participating pharmacies in Western and Northern Ontario. Each participating pharmacy is now able to administer the Med-Minder device for their patients. This field trial is a continuation of previous market research that used focus groups comprised of both patients and industry professionals. These focus groups provided very favourable feedback on product features.
Last month the Med-Minder Adherence System was displayed at the National Drug Trading Show, where it received great acclaims. For more information regarding the Med-Minder product, please contact Mr. John Girgis, President of Med-Minder Enterprises Inc., at 1-877-MEDMIND (1-877-633-6463), jgirgis@med-minder.com or visit their website at http://www.med-minder.com.
ZTEST offers Strategic Partner services in electronic design, development and manufacturing to emerging high tech companies in return for long-term manufacturing contracts, fees for services and equity positions.
For further information, please contact Mr. James E. Lalonde, Manager, Corporate Development, at (905) 569-3344 or visit our website at http://www.ztest.com.
The current outstanding capital of ZTEST is 18,744,566 common shares.